Arix Bioscience PLC
LSE:ARIX
Arix Bioscience PLC
LSE:ARIX
Price:
142 GBX
Market Closed
Updated:
May 5, 2024
Arix Bioscience PLC
Cash from Operating Activities
|
Arix Bioscience PLC
Cash from Operating Activities Peer Comparison
Comparables:
JHG
III
SDR
ICP
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arix Bioscience PLC
LSE:ARIX
|
Cash from Operating Activities
-£4.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Cash from Operating Activities
$441.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Cash from Operating Activities
£505m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-3%
|
|
|
Schroders PLC
LSE:SDR
|
Cash from Operating Activities
-£238.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intermediate Capital Group PLC
LSE:ICP
|
Cash from Operating Activities
£83.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
See Also
What is Arix Bioscience PLC's Cash from Operating Activities?
Cash from Operating Activities
-4.6m
GBP
-4.6m
GBP
Based on the financial report for Dec 31, 2022, Arix Bioscience PLC's Cash from Operating Activities amounts to -4.6m GBP.
What is Arix Bioscience PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
12%
12%
Over the last year, the Cash from Operating Activities growth was 35%. The average annual Cash from Operating Activities growth rates for Arix Bioscience PLC have been 18% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
